|
13 Apr 2025 |
Shree Cements
|
Consensus Share Price Target
|
30107.95 |
27694.79 |
- |
-8.02 |
hold
|
|
|
|
|
01 Feb 2025
|
Shree Cements
|
KRChoksey
|
30107.95
|
30619.00
|
27363.75
(10.03%)
|
Target met |
Accumulate
|
|
|
Shree Cement’s Q3FY25 performance missed our projections. Revenue declined to INR 45,727 Mn, down 12.0% YoY (+12.8% QoQ). The QoQ growth was driven by robust volume expansion partially offset by decline in realization.
|
|
16 Dec 2024
|
Shree Cements
|
Geojit BNP Paribas
|
30107.95
|
29435.00
|
28091.25
(7.18%)
|
Target met |
Hold
|
|
|
|
|
12 Nov 2024
|
Shree Cements
|
KRChoksey
|
30107.95
|
25575.00
|
24372.80
(23.53%)
|
Target met |
Accumulate
|
|
|
Shree Cement’s Q2FY25 result missed our projections despite revenue in line with our estimates. Revenue declined to INR 40,542 Mn, down 15.1% YoY (-20.9% QoQ) due to weaker realization and a decline in volumes.
|
|
12 Nov 2024
|
Shree Cements
|
IDBI Capital
|
30107.95
|
25446.00
|
24372.80
(23.53%)
|
Target met |
Hold
|
|
|
|
|
12 Nov 2024
|
Shree Cements
|
Anand Rathi
|
30107.95
|
28600.00
|
24372.80
(23.53%)
|
Target met |
Buy
|
|
|
Shree Cements’ Q2 was muted due to the weak demand-pricing environment, owing to prolonged monsoons and low infrastructure spends by the government.
|
|
12 Nov 2024
|
Shree Cements
|
Sharekhan
|
30107.95
|
28800.00
|
24372.80
(23.53%)
|
Target met |
Buy
|
|
|
We retain a Buy rating on Shree Cement with a revised PT of Rs. 28,800, factoring a marginal downward revision in operational profitability led by lower volume growth than earlier envisaged.
|
|
12 Nov 2024
|
Shree Cements
|
Axis Direct
|
30107.95
|
25560.00
|
24372.80
(23.53%)
|
Target met |
Hold
|
|
|
We maintain our HOLD rating on the company
|
|
12 Nov 2024
|
Shree Cements
|
BOB Capital Markets Ltd.
|
30107.95
|
24140.00
|
24372.80
(23.53%)
|
Target met |
Hold
|
|
|
Realisation dent drags revenue growth by a steep 19%/23% in Q2FY25, partially offset by relatively lower volume decline of 7% YoY
|
|
11 Nov 2024
|
Shree Cements
|
Motilal Oswal
|
30107.95
|
23910.00
|
24418.25
(23.30%)
|
Target met |
Neutral
|
|
|
Shree Cement (SRCM)’s 2QFY25 EBITDA was in line as lower-than-estimated realization/t was offset by lower-than-estimated opex/t.
|
|
15 Oct 2024
|
Shree Cements
|
BOB Capital Markets Ltd.
|
30107.95
|
25422.00
|
24718.50
(21.80%)
|
Target met |
Hold
|
|
|
Maintaining market share will be the key priority in the supply glut market situation, though capacity utilisation may hover ~70%
|
|
09 Aug 2024
|
Shree Cements
|
KRChoksey
|
30107.95
|
26083.00
|
24296.60
(23.92%)
|
Target met |
Accumulate
|
|
|
Shree Cement’s Q1FY25 result missed our projections despite revenue in line with our estimates. Despite falling cement prices, revenue increased 1.8% YoY (-5.1% QoQ) to INR 51,240 Mn led by strong volume growth.
|
|
08 Aug 2024
|
Shree Cements
|
Axis Direct
|
30107.95
|
25610.00
|
24143.40
(24.70%)
|
Target met |
Hold
|
|
|
We change our rating from BUY to HOLD
|
|
08 Aug 2024
|
Shree Cements
|
ICICI Direct
|
30107.95
|
27140.00
|
24143.40
(24.70%)
|
Target met |
Hold
|
|
|
|
|
08 Aug 2024
|
Shree Cements
|
ICICI Securities Limited
|
30107.95
|
24184.00
|
24143.40
(24.70%)
|
Target met |
Hold
|
|
|
Shree Cement’s (SRCM) volume focus in Q1FY25 was exceptional given it stood flat QoQ (up 8% YoY) as against 5-20% drop reported by industry majors.
|
|
07 Aug 2024
|
Shree Cements
|
Motilal Oswal
|
30107.95
|
27500.00
|
25098.60
(19.96%)
|
Target met |
Neutral
|
|
|
Shree Cement (SRCM)’s 1QFY25 EBITDA was significantly below our estimate, primarily due to a lower-than-estimated realization (6% miss).
|
|
07 Aug 2024
|
Shree Cements
|
Sharekhan
|
30107.95
|
28000.00
|
25098.60
(19.96%)
|
Target met |
Buy
|
|
|
Standalone revenues marginally lagged estimates at Rs. 4835 crore (down 2.7% y-o-y) as lower than estimated realisations (down 10% y-o-y, on higher sales in the Eastern region.
|
|
23 May 2024
|
Shree Cements
|
BOB Capital Markets Ltd.
|
30107.95
|
27438.00
|
25676.90
(17.26%)
|
Target met |
Hold
|
|
|
JKCE: Focused on growth; earnings intact; upgrade to BUY. RBI Dividend: Record high. SRCM: Cost savings key driver of performance; valuations pricey. BANDHAN: In line with recovery plan. ERIS: Strong revenue growth; integration ongoing. MTLM: Misses estimate on weak plywood margin; upbeat outlook.
|
|
21 May 2024
|
Shree Cements
|
BP Wealth
|
30107.95
|
|
25833.45
(16.55%)
|
|
Results Update
|
|
|
|
|
21 May 2024
|
Shree Cements
|
KRChoksey
|
30107.95
|
30662.00
|
25833.45
(16.55%)
|
Target met |
Buy
|
|
|
Shree Cement reported better-than-expected numbers, which beat estimates across the board. Revenue increased 6.5% YoY to INR 54,328 Mn due to strong volume growth despite pressure on cement prices.
|
|
16 May 2024
|
Shree Cements
|
Axis Direct
|
30107.95
|
29350.00
|
25685.60
(17.22%)
|
Target met |
Buy
|
|
|
We maintain our BUY rating on the stock.
|